Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen E Remotti

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Gastroenterology|November 1, 2020
PD-1 Signaling Promotes Tumor-Infiltrating Myeloid-Derived Suppressor Cells and Gastric Tumorigenesis in MiceWoosook Kim, Timothy H Chu, Henrik Nienhüser, et al.
JCI Insight|March 23, 2021
LIN28B induces a differentiation program through CDX2 in colon cancerKensuke Suzuki, Yasunori Masuike, Rei Mizuno, et al.
Plos One|March 25, 2015
Smad4 loss synergizes with TGFα overexpression in promoting pancreatic metaplasia, PanIN development, and fibrosisDario Garcia-Carracedo, Chih-Chieh Yu, Nathan Akhavan, et al.
Oncotarget|November 25, 2011
Disruption of p16 and activation of Kras in pancreas increase ductal adenocarcinoma formation and metastasis in vivoWanglong Qiu, Fikret Sahin, Christine A Iacobuzio-Donahue, et al.
Cancer Letters|November 18, 2018
HHLA2 is a novel immune checkpoint protein in pancreatic ductal adenocarcinoma and predicts post-surgical survivalHan Yan, Wanglong Qiu, Anne K Koehne de Gonzalez, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 5, 2011
RAGE gene deletion inhibits the development and progression of ductal neoplasia and prolongs survival in a murine model of pancreatic cancerJoseph DiNorcia, Minna K Lee, Dorota N Moroziewicz, et al.
The Journal of Allergy and Clinical Immunology|September 15, 2024
Systemic T-cell activation and IFN-γ activity in indeterminate severe hepatitis are reminiscent of hemophagocytic lymphohistiocytosis: Implications for T-cell- and IFN-γ-directed therapiesThinh H Nguyen, Prakash Satwani, Deepak Kumar, et al.
Gastroenterology|September 27, 2015
Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRASWanglong Qiu, Sophia M Tang, Sohyae Lee, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|October 17, 2025
Combined HDAC and eIF4A inhibition: A novel epigenetic therapy for pancreatic ductal adenocarcinomaMaryam Safari, Luigi Scotto, Agnes Basseville, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 15, 2020
Hepatic pathology in patients dying of COVID-19: a series of 40 cases including clinical, histologic, and virologic dataStephen M Lagana, Satoru Kudose, Alina C Iuga, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Gastroenterology|November 1, 2020
PD-1 Signaling Promotes Tumor-Infiltrating Myeloid-Derived Suppressor Cells and Gastric Tumorigenesis in MiceWoosook Kim, Timothy H Chu, Henrik Nienhüser, et al.
JCI Insight|March 23, 2021
LIN28B induces a differentiation program through CDX2 in colon cancerKensuke Suzuki, Yasunori Masuike, Rei Mizuno, et al.
Plos One|March 25, 2015
Smad4 loss synergizes with TGFα overexpression in promoting pancreatic metaplasia, PanIN development, and fibrosisDario Garcia-Carracedo, Chih-Chieh Yu, Nathan Akhavan, et al.
Oncotarget|November 25, 2011
Disruption of p16 and activation of Kras in pancreas increase ductal adenocarcinoma formation and metastasis in vivoWanglong Qiu, Fikret Sahin, Christine A Iacobuzio-Donahue, et al.
Cancer Letters|November 18, 2018
HHLA2 is a novel immune checkpoint protein in pancreatic ductal adenocarcinoma and predicts post-surgical survivalHan Yan, Wanglong Qiu, Anne K Koehne de Gonzalez, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 5, 2011
RAGE gene deletion inhibits the development and progression of ductal neoplasia and prolongs survival in a murine model of pancreatic cancerJoseph DiNorcia, Minna K Lee, Dorota N Moroziewicz, et al.
The Journal of Allergy and Clinical Immunology|September 15, 2024
Systemic T-cell activation and IFN-γ activity in indeterminate severe hepatitis are reminiscent of hemophagocytic lymphohistiocytosis: Implications for T-cell- and IFN-γ-directed therapiesThinh H Nguyen, Prakash Satwani, Deepak Kumar, et al.
Gastroenterology|September 27, 2015
Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRASWanglong Qiu, Sophia M Tang, Sohyae Lee, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|October 17, 2025
Combined HDAC and eIF4A inhibition: A novel epigenetic therapy for pancreatic ductal adenocarcinomaMaryam Safari, Luigi Scotto, Agnes Basseville, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 15, 2020
Hepatic pathology in patients dying of COVID-19: a series of 40 cases including clinical, histologic, and virologic dataStephen M Lagana, Satoru Kudose, Alina C Iuga, et al.
Pageof 5